BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank100
Studio
Year-over-Year Change

Free cash flow yield

Latest
20.00%
↑ 375% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
-7.27%
Historical baseline
PeriodValueYoY Change
202520.00%+684.9%
2024-3.42%+59.5%
2023-8.45%-10.5%
2022-7.65%-31.2%
2021-5.83%+47.3%
2020-11.05%+51.0%
2019-22.55%-102.0%
2018-11.16%-11.6%
2017-10.00%+20.5%
2016-12.59%-